HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lack of Relevant Haemogram Changes During Percutaneous Radiotherapy of Localised Prostate Cancer.

AbstractBACKGROUND/AIM:
In percutaneous radiotherapy dose-distribution and volumetric-load of normal tissue varies in different radiation-techniques. Haematotoxicity may lead to deficiencies of the immune and blood system or to secondary malignancies. Therefore, regular blood-counts are carried out during fractionated radiotherapy. The aim was to investigate patient haemogram courses during radiotherapy of localised prostate-cancer treated with different radiation-techniques (n=3).
PATIENTS AND METHODS:
In this prospective study, blood count changes were examined during fractionated radiotherapy (3D-conformal-RT/step-and-shoot-IMRT/helical-IMRT) on the prostate-region in localised prostate-cancer cases (n=50).
RESULTS:
The whole patient group displayed a small but significant reduction in leukocytes. This reduction was higher in the two IMRT groups compared to the 3D-group but without any case of leukopenia. Haemoglobin- or thrombocyte-levels did not significantly change.
CONCLUSION:
Regardless of the delivery mode used, localised fractionated irradiation of prostate region did not cause any clinically relevant haemogram changes in this study. These findings question the necessity of regular blood counts during fractionated radiotherapy of the prostate region for patients without any risk factors.
AuthorsFelix Zwicker, Benedict Swartman, Peter E Huber, Klaus Herfarth, Jürgen Debus, Henrik Hauswald
JournalIn vivo (Athens, Greece) (In Vivo) 2020 May-Jun Vol. 34 Issue 3 Pg. 1555-1563 ISSN: 1791-7549 [Electronic] Greece
PMID32354962 (Publication Type: Journal Article)
CopyrightCopyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Topics
  • Aged
  • Aged, 80 and over
  • Blood Cell Count
  • Dose-Response Relationship, Radiation
  • Humans
  • Male
  • Middle Aged
  • Prostatic Neoplasms (blood, pathology, radiotherapy)
  • Radiotherapy Dosage
  • Radiotherapy Planning, Computer-Assisted
  • Radiotherapy, Conformal (adverse effects, methods)
  • Radiotherapy, Intensity-Modulated (adverse effects, methods)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: